| Application no. and date | 10760140.3 (espacenet) (Federated) (European Patent Register), 20100916 | | Patent/reg. no. and date | DK/EP 2477603, 20160330 | | Publication date | 20120725 | | Priority no. and date | US 277045 P, 20090917 | | EP pub. no. and date |
EP 2477603 20120725 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku
Osaka-Shi, Osaka, JP | | Applicant ref. no. | P58761DK01 | | Inventor | WEBER, Alfred, Skraupstrasse 24/42/8
A-1210 Wien, AT,
TESCHNER, Wolfgang, Gestettengasse 19/14
A-1030 Wien, AT,
SVATOS, Sonja, Kapellengasse 42
A-2413 Berg, AT,
BRUCKSCHWAIGER, Leopold, Herminengasse 5/14
A-1020 Wien, AT,
SCHWARZ, Hans-Peter, Weimarer Strasse 76
A-1180 Wien, AT,
LEI, Laura, 11452 Clarkson Road
Los Angeles
CA 90064, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/36 (2006.01) , A61K 47/42 (2006.01) , A61K 9/00 (2006.01) , C07K 16/00 (2006.01) , C07K 16/06 (2006.01) , C12N 9/24 (2006.01) | | Title | STABIL CO-FORMULERING AF HYALURONIDASE OG IMMUNOGLOBULIN, OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2010002545 | | Int. publication no. | WO2011034604 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
